156 related articles for article (PubMed ID: 23939898)
1. Quantification of brain voriconazole levels in healthy adults using fluorine magnetic resonance spectroscopy.
Henry ME; Bolo NR; Zuo CS; Villafuerte RA; Cayetano K; Glue P; Damle BD; Andrews E; Lauriat TL; Rana NS; Churchill JH; Renshaw PF
Antimicrob Agents Chemother; 2013 Nov; 57(11):5271-6. PubMed ID: 23939898
[TBL] [Abstract][Full Text] [Related]
2. Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections.
Boyd NK; Zoellner CL; Swancutt MA; Bhavan KP
Antimicrob Agents Chemother; 2012 Nov; 56(11):6001-2. PubMed ID: 22890768
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in Hispaniolan Amazon parrots (Amazona ventralis).
Sanchez-Migallon Guzman D; Flammer K; Papich MG; Grooters AM; Shaw S; Applegate J; Tully TN
Am J Vet Res; 2010 Apr; 71(4):460-7. PubMed ID: 20367055
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent.
Purkins L; Wood N; Greenhalgh K; Eve MD; Oliver SD; Nichols D
Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):2-9. PubMed ID: 14616407
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.
Purkins L; Wood N; Ghahramani P; Greenhalgh K; Allen MJ; Kleinermans D
Antimicrob Agents Chemother; 2002 Aug; 46(8):2546-53. PubMed ID: 12121931
[TBL] [Abstract][Full Text] [Related]
6. Integrated population pharmacokinetic analysis of voriconazole in children, adolescents, and adults.
Friberg LE; Ravva P; Karlsson MO; Liu P
Antimicrob Agents Chemother; 2012 Jun; 56(6):3032-42. PubMed ID: 22430956
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies.
Karlsson MO; Lutsar I; Milligan PA
Antimicrob Agents Chemother; 2009 Mar; 53(3):935-44. PubMed ID: 19075073
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults.
Driscoll TA; Frangoul H; Nemecek ER; Murphey DK; Yu LC; Blumer J; Krance RA; Baruch A; Liu P
Antimicrob Agents Chemother; 2011 Dec; 55(12):5780-9. PubMed ID: 21911570
[TBL] [Abstract][Full Text] [Related]
9. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
Andes D; Marchillo K; Stamstad T; Conklin R
Antimicrob Agents Chemother; 2003 Oct; 47(10):3165-9. PubMed ID: 14506026
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh).
Flammer K; Nettifee Osborne JA; Webb DJ; Foster LE; Dillard SL; Davis JL
Am J Vet Res; 2008 Jan; 69(1):114-21. PubMed ID: 18167096
[TBL] [Abstract][Full Text] [Related]
11. Determination of the antifungal agent voriconazole in human plasma using a simple column-switching high-performance liquid chromatography and its application to a pharmacokinetic study.
Nakagawa S; Suzuki R; Yamazaki R; Kusuhara Y; Mitsumoto S; Kobayashi H; Shimoeda S; Ohta S; Yamato S
Chem Pharm Bull (Tokyo); 2008 Mar; 56(3):328-31. PubMed ID: 18310944
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of voriconazole after single dose intravenous and oral administration to alpacas.
Chan HM; Duran SH; Walz PH; Ravis WR
J Vet Pharmacol Ther; 2009 Jun; 32(3):235-40. PubMed ID: 19646087
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
Clifton IJ; Whitaker P; Metcalfe R; Phillip M; Shaw N; Conway SP; Peckham DG
J Antimicrob Chemother; 2011 Oct; 66(10):2438-40. PubMed ID: 21791443
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients.
Peng LW; Lien YH
Am J Kidney Dis; 2005 Jan; 45(1):162-6. PubMed ID: 15696456
[TBL] [Abstract][Full Text] [Related]
15. Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients.
Bartelink IH; Wolfs T; Jonker M; de Waal M; Egberts TC; Ververs TT; Boelens JJ; Bierings M
Antimicrob Agents Chemother; 2013 Jan; 57(1):235-40. PubMed ID: 23114771
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.
Dodds Ashley ES; Zaas AK; Fang AF; Damle B; Perfect JR
Antimicrob Agents Chemother; 2007 Mar; 51(3):877-80. PubMed ID: 17145785
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of voriconazole in children.
Chen J; Chan C; Colantonio D; Seto W
Ther Drug Monit; 2012 Feb; 34(1):77-84. PubMed ID: 22210097
[TBL] [Abstract][Full Text] [Related]
18. Voriconazole plasma levels in children are highly variable.
Spriet I; Cosaert K; Renard M; Uyttebroeck A; Meyts I; Proesmans M; Meyfroidt G; de Hoon J; Verbesselt R; Willems L
Eur J Clin Microbiol Infect Dis; 2011 Feb; 30(2):283-7. PubMed ID: 20963460
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype.
Scholz I; Oberwittler H; Riedel KD; Burhenne J; Weiss J; Haefeli WE; Mikus G
Br J Clin Pharmacol; 2009 Dec; 68(6):906-15. PubMed ID: 20002085
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of voriconazole during continuous venovenous hemofiltration.
Spriet I; Wauters J; Willems L
Ther Drug Monit; 2011 Jun; 33(3):372; author reply 372. PubMed ID: 21566509
[No Abstract] [Full Text] [Related]
[Next] [New Search]